Skip to Content


In the US, Tigecycline (tigecycline systemic) is a member of the drug class glycylcyclines and is used to treat Intraabdominal Infection, Pneumonia, Skin and Structure Infection and Skin or Soft Tissue Infection.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Glycylcycline

Chemical Names

(4S,4aS,5aR,12aS)-4,7-bis(dimetylamino)-9-[(tert-butylamino)acetamido]-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-carbamid (IUPAC)

(4S,4aS,5aR,12aS)-4,7-Bis(dimetylamino)-9-[[[(1,1-dimetyletyl)amino]acetyl]amino]-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (WHO)

2-Naphtacenecarboxamide, 4,7,bis(dimetylamino)-9-[[[(1,1-dimetyletyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahxdroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- (USAN)

Foreign Names

  • Tigecyclinum (Latin)
  • Tigecycline (German)
  • Tigecycline (French)
  • Tigeciclina (Spanish)

Generic Names

  • Tigecycline (OS: USAN, BAN, JAN)
  • CL-329998 (IS)
  • CL-331002 (IS)
  • GAR-936 (IS)
  • WAY-GAR-936 (IS: Wyeth)

Brand Names

  • Haizheng Lixing
    Hisun Pfizer, China
  • Tigacil
    Incepta, Bangladesh
  • Tigebax
    Glenmark, India
  • Tize-B
    Health Biotech, India
  • Tizoxim
    Richmond, Argentina
  • Tygacil
    Pfizer, Argentina; Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, China; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Ecuador; Pfizer, Egypt; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Indonesia; Pfizer, Ireland; Pfizer, Israel; Pfizer, Iceland; Pfizer, South Korea; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, New Zealand; Pfizer, Philippines; Pfizer, Poland; Pfizer, Portugal; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Slovakia; Pfizer, Thailand; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Japan, Japan; Pfizer Luxembourg, Bosnia & Herzegowina; Wyeth, Chile; Wyeth, Spain; Wyeth, Latvia; Wyeth, Oman; Wyeth, Romania; Wyeth, Serbia; Wyeth, Tunisia; Wyeth Medica, Lithuania; Wyeth, Inc., United States; Pfizer, Peru


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.